Therapeutic Window in Drug Therapy

Introduction to Therapeutic Window

The therapeutic window represents the critical balance between efficacy and safety in drug therapy, defined as the range of drug dosage that provides sufficient concentration to achieve therapeutic effect, remains below levels that would cause unacceptable toxicity, and optimizes the benefit-to-harm ratio 1
The concept of therapeutic window is fundamental to clinical pharmacology and drug development, directly impacting patient safety and treatment outcomes, drug dosing strategies, and therapeutic drug monitoring requirements 1

Between-subject variability (BSV) and between-occasion variability (BOV) affect drug metabolism and response, influencing the therapeutic window of medications 1
Drug-specific properties, such as narrow therapeutic index drugs, require more precise dosing to maintain an optimal therapeutic window 1

Traditional Therapeutic Drug Monitoring (TDM) compares patient plasma drug concentrations against defined therapeutic windows to guide dosing decisions, particularly important for drugs with narrow therapeutic indices and significant toxicity concerns 1
Traditional TDM has limitations, including the need for sampling within specific time windows and the potential for single samples to not adequately capture variability, which can lead to suboptimal outcomes for some individuals 1

More advanced approaches use mathematical models to optimize dosing, combining patient characteristics with population pharmacokinetic models and accounting for multiple covariates and sources of variability to provide more informed dosing recommendations 1
Model-Informed Precision Dosing (MIPD) is particularly valuable for drugs with known exposure-response/exposure-safety relationships, narrow therapeutic indices, and wide between-subject variability, especially for high-risk patient populations 1

Preclinical studies define minimum effective and maximum tolerated doses, helping to establish the therapeutic window for new drugs 2